Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2010, Vol. 4 Issue (2) : 139-146    https://doi.org/10.1007/s11684-010-0033-6
Research articles
Review of hand, foot and mouth disease
Lan-Juan LI MD,
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China;
 Download: PDF(201 KB)  
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract Hand, foot and mouth disease (HFMD) is an acute viral illness that primarily affects infants and young children, and often occurs in clusters or outbreaks. The major causative agents of HFMD are coxsackievirus A16 (CVA16), human enterovirus 71 (HEV71) and coxsackievirus A10 (CVA10), of the genus Enterovirus in the family Picornaviridae. HFMD caused by EV71 is associated with severe neurological complications and death. Since the late 1990s, several major epidemics of EV71 HFMD have swept through the Asia-Pacific region, associated with a rapid fulminant course, severe neurological complications, and a large number of fatalities. Until now, little has been known about the genetics and transmission trends of the fast-mutation virus, and there is no effective and specific antiviral therapy or vaccine for HFMD. It is time to step up efforts to understand the molecular epidemics and pathogenesis so that we can develop effective management strategies and surveillance programs.
Keywords hand, foot and mouth disease      epidemiology      pathogenesis      management      surveillance      
Issue Date: 05 June 2010
 Cite this article:   
Lan-Juan LI MD. Review of hand, foot and mouth disease[J]. Front. Med., 2010, 4(2): 139-146.
 URL:  
https://academic.hep.com.cn/fmd/EN/10.1007/s11684-010-0033-6
https://academic.hep.com.cn/fmd/EN/Y2010/V4/I2/139
Yan J J, Su I J, Chen P F, Liu C C, Yu C K, Wang J R. Complete genome analysis of enterovirus 71 isolated froman outbreak in Taiwan and rapid identification of enterovirus 71 andcoxsackievirus A16 by RT-PCR. J Med Virol, 2001, 65(2): 331–339

doi: 10.1002/jmv.2038
Bible J M, Pantelidis P, Chan P K, Tong C Y. Genetic evolution of enterovirus 71: epidemiologicaland pathological implications. Rev Med Virol, 2007, 17(6): 371–379

doi: 10.1002/rmv.538
Schmidt N J, Lennette E H, Ho H H. An apparently new enterovirusisolated from patients with disease of the central nervous system. J Infect Dis, 1974, 129(3): 304–309
Deibel R, Gross L L, Collins D N. Isolation of a new enterovirus (38506). Proc Soc Exp Biol Med, 1975, 148(1): 203–207
Blomberg J, Lycke E, Ahlfors K, Johnsson T, Wolontis S, von Zeipel G. Letter: New enterovirus type associated with epidemicof aseptic meningitis and-or hand, foot, and mouth disease. Lancet, 1974, 2(7872): 112

doi: 10.1016/S0140-6736(74)91684-5
Tagaya I, Tachibana K. Epidemic of hand, foot and mouth disease in Japan, 1972―1973: differencein epidemiologic and virologic features from the previous one. Jpn J Med Sci Biol, 1975, 28(4): 231–234
Gilbert G L, Dickson K E, Waters M J, Kennett M L, Land S A, Sneddon M. Outbreak of enterovirus 71 infectionin Victoria, Australia, with a high incidence of neurologic involvement. Pediatr Infect Dis J, 1988, 7(7): 484–488

doi: 10.1097/00006454-198807000-00007
Shindarov L M, Chumakov M P, Voroshilova M K, Bojinov S, Vasilenko S M, Iordanov I, Kirov I D, Kamenov E, Leshchinskaya E V, Mitov G, Robinson I A, Sivchev S, Staikov S. Epidemiological, clinical, and pathomorphological characteristicsof epidemic poliomyelitis-like disease caused by enterovirus 71. J Hyg Epidemiol Microbiol Immunol, 1979, 23(3): 284–295
Nagy G, Takatsy S, Kukan E, Mihaly I, Domok I. Virological diagnosis of enterovirus type 71 infections: experiences gained duringan epidemic of acute CNS diseases in Hungary in 1978. Arch Virol, 1982, 71(3): 217–227

doi: 10.1007/BF01314873
World Health Organization. Outbreak of hand, foot and mouth disease in Sarawak.Cluster of deaths among infants and young children. Wkly Epidemiol Rec, 1997, 72(28): 211–212
Lin T Y, Chang L Y, Hsia S H, Huang Y C, Chiu C H, Hsueh C, Shih S R, Liu C C, Wu M H. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis, 2002, 34 Suppl 2: S52–57

doi: 10.1086/338819
Shimizu H, Utama A, Onnimala N, Li C, Li-Bi Z, Yu-Jie M, Pongsuwanna Y, Miyamura T. Molecular epidemiology ofenterovirus 71 infection in the Western Pacific Region. Pediatr Int, 2004, 46(2): 231–235

doi: 10.1046/j.1442-200x.2004.01868.x
AbuBakar S, Chee H Y, Al-Kobaisi M F, Xiaoshan J, Chua K B, Lam S K. Identification of enterovirus 71 isolatesfrom an outbreak of hand, foot and mouth disease (HFMD) with fatalcases of encephalomyelitis in Malaysia. Virus Res, 1999, 61(1): 1–9

doi: 10.1016/S0168-1702(99)00019-2
Lum L C, Wong K T, Lam S K, Chua K B, Goh A Y, Lim W L, Ong B B, Paul G, AbuBakar S, Lambert M. Fatal enterovirus 71 encephalomyelitis, J Pediatr, 1998, 133(6): 795–798

doi: 10.1016/S0022-3476(98)70155-6
Qiu J. Viral outbreak in China tests government efforts. Nature, 2009, 458(7238): 554–555

doi: 10.1038/458554a
Li L, He Y, Yang H, Zhu J, Xu X, Dong J, Zhu Y, Jin Q. Genetic characteristics of human enterovirus71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen,people's Republic of China. J Clin Microbiol, 2005, 43(8): 3835–3839

doi: 10.1128/JCM.43.8.3835-3839.2005
Yang F, Ren L, Xiong Z, Li J, Xiao Y, Zhao R, He Y, Bu G, Zhou S, Wang J, Qi J. Enterovirus 71 outbreak in the people's Republic of China in 2008. J Clin Microbiol, 2009, 47(7): 2351–2352

doi: 10.1128/JCM.00563-09
http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohbgt/s3582/200903/39757.htm
http://gov.rednet.cn/c/2009/04/10/1742172.htm (in Chinese)
Brown B A, Oberste M S, Alexander J P Jr, Kennett M L, Pallansch M A. Molecular epidemiology and evolution of enterovirus 71 strains isolatedfrom 1970 to 1998. J Virol, 1999, 73(12): 9969–9975
McMinn P, Lindsay K, Perera D, Chan H M, Chan K P, Cardosa M J. Phylogenetic analysis of enterovirus71 strains isolated during linked epidemics in Malaysia, Singapore,and Western Australia. J Virol, 2001, 75(16): 7732–7738

doi: 10.1128/JVI.75.16.7732-7738.2001
Tong C, Bible J. Global epidemiology of Enterovirus 71. Future Virol, 2009, 4(5): 501–510

doi: 10.2217/fvl.09.25
Zhang Y, Tan X J, Wang H Y, Yan D M, Zhu S L, Wang D Y, Ji F, Wang X J, Gao Y J, Chen L, An H Q, Li D X, Wang S W, Xu A Q, Wang Z J, Xu W B. An outbreak of hand, foot, and mouth disease associatedwith subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol, 2009, 44(4): 262–267

doi: 10.1016/j.jcv.2009.02.002
Huang S C, Hsu Y W, Wang H C, Huang S W, Kiang D, Tsai H P, Wang S M, Liu C C, Lin K H, Su I J, Wang J R. Appearance of intratypic recombination of enterovirus71 in Taiwan from 2002 to 2005. Virus Res, 2008, 131(2): 250–259

doi: 10.1016/j.virusres.2007.10.002
Yoke-Fun C, AbuBakar S. Phylogenetic evidence for inter-typic recombination in the emergence of human enterovirus71 subgenotypes. BMC Microbiol, 2006, 6: 74

doi: 10.1186/1471-2180-6-74
Ding N Z, Wang X M, Sun S W, Song Q, Li S N, He C Q. Appearance of mosaic enterovirus 71 in the 2008 outbreakof China. Virus Res, 2009, 145(1): 157–161

doi: 10.1016/j.virusres.2009.06.006
Ho H Y, Cheng M L, Weng S F, Chang L, Yeh T T, Shih S R, Chiu D T. Glucose-6-phosphatedehydrogenase deficiency enhances enterovirus 71 infection. J Gen Virol, 2008, 89(Pt 9): 2080–2089

doi: 10.1099/vir.0.2008/001404-0
Chang L Y, Chang I S, Chen W J, Huang Y C, Chen G W, Shih S R, Juang J L, Shih H M, Hsiung C A, Lin T Y, Huang L M. HLA-A33 is associated with susceptibility to enterovirus71 infection. Pediatrics, 2008, 122(6): 1271–1276

doi: 10.1542/peds.2007-3735
Huemer H P, Ortner B, Huang C W, Schmid D, Mutz I, Wewalka G, Yang J Y, Allerberger F. Isolating Asian enterovirus71 subgenogroup C4 in two Austrian clinical samples from 2004. Euro Surveill, 2008, 13(28): pii: 18922
Zhang Y, Tan X J, Wang H Y, Yan D M, Zhu S L, Wang D Y, Ji F, Wang X J, Gao Y J, Chen L, An H Q, Li D X, Wang S W, Xu A Q, Wang Z J, Xu W B. An outbreak of hand, foot, and mouth disease associatedwith subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol, 2009, 44(4): 262–267

doi: 10.1016/j.jcv.2009.02.002
Qiu J. Enterovirus 71 infection: a new threat to global publichealth? Lancet Neurol, 2008, 7(10): 868–869

doi: 10.1016/S1474-4422(08)70207-2
Chen L C, Shyu H W, Chen S H, Lei H Y, Yu C K, Yeh T M. Enterovirus 71 infection induces Fas ligand expressionand apoptosis of Jurkat cells. J Med Virol, 2006, 78(6): 780–786

doi: 10.1002/jmv.20623
Chang S C, Lin J Y, Lo L Y, Li M L, Shih S R. Diverse apoptotic pathwaysin enterovirus 71-infected cells. J Neurovirol, 2004, 10(6): 338–349

doi: 10.1080/13550280490521032
Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, Koike S. Scavenger receptor B2 is a cellular receptor for enterovirus71. Nat Med, 2009, 15(7): 798–801

doi: 10.1038/nm.1992
Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. Human P-selectin glycoproteinligand-1 is a functional receptor for enterovirus 71. Nat Med, 2009, 15(7): 794–797

doi: 10.1038/nm.1961
Lin T Y, Chang L Y, Hsia S H, Huang Y C, Chiu C H, Hsueh C, Shih S R, Liu C C, Wu M H. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis, 2002, 34 (Suppl 2): S52–57

doi: 10.1086/338819
Chang L Y, Hsia S H, Wu C T, Huang Y C, Lin K L, Fang T Y, Lin T Y. Outcome of enterovirus 71 infections with or without stage-based management:1998 to 2002. Pediatr Infect Dis J, 2004, 23(4): 327–332

doi: 10.1097/00006454-200404000-00010
Chang L Y, Lin T Y, Hsu K H, Huang Y C, Lin K L, Hsueh C, Shih S R, Ning H C, Hwang M S, Wang H S, Lee C Y. Clinical features and risk factors of pulmonary oedemaafter enterovirus-71-related hand, foot, and mouth disease. Lancet, 1999; 354(9191): 1682–1686

doi: 10.1016/S0140-6736(99)04434-7
Wang S M, Lei H Y, Huang M C, Su L Y, Lin H C, Yu C K, Wang J L, Liu C C. Modulation of cytokine production byintravenous immunoglobulin in patients with enterovirus 71-associatedbrainstem encephalitis. J Clin Virol, 2006, 37(1): 47–52

doi: 10.1016/j.jcv.2006.05.009
Wang S M, Lei H Y, Huang M C, Wu J M, Chen C T, Wang J N, Wang J R, Liu C C. Therapeutic efficacy of milrinone inthe management of enterovirus 71-induced pulmonary edema. Pediatr Pulmonol, 2005, 39(3): 219–223

doi: 10.1002/ppul.20157
Chang L Y. Enterovirus 71 in Taiwan. Pediatr Neonatol, 2008, 49(4): 103–112

doi: 10.1016/S1875-9572(08)60023-6
Chen T C, Weng K F, Chang S C, Lin J Y, Huang P N, Shih S R. Development of antiviral agents for enteroviruses. J Antimicrob Chemother, 2008, 62(6): 1169–1173

doi: 10.1093/jac/dkn424
Pevear D C, Tull T M, Seipel M E, Groarke J M. Activity of pleconaril against enteroviruses. Antimicrob Agents Chemother, 1999, 43(9): 2109–2115
Shia K S, Li W T, Chang C M, Hsu M C, Chern J H, Leong M K, Tseng S N, Lee C C, Lee Y C, Chen S J, Peng K C, Tseng H Y, Chang Y L, Tai C L, Shih S R. Design, synthesis, and structure-activityrelationship of pyridyl imidazolidinones: a novel class of potentand selective human enterovirus 71 inhibitors. J Med Chem, 2002, 45(8): 1644–1655

doi: 10.1021/jm010536a
Li Z H, Li C M, Ling P, Shen F H, Chen S H, Liu C C, Yu C K. Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viralreplication. J Infect Dis, 2008, 197(6): 854–857

doi: 10.1086/527326
Foo D G, Alonso S, Phoon M C, Ramachandran N P, Chow V T, Poh C L. Identification of neutralizinglinear epitopes from the VP1 capsid protein of Enterovirus 71 usingsynthetic peptides. Virus Res, 2007, 125(1): 61–68

doi: 10.1016/j.virusres.2006.12.005
Chen H L, Huang J Y, Chu T W, Tsai T C, Hung C M, Lin C C, Liu F C, Wang L C, Chen Y J, Lin M F, Chen C M. Expression of VP1 protein in the milk of transgenic mice:a potential oral vaccine protects against enterovirus 71 infection. Vaccine, 2008, 26(23): 2882–2889

doi: 10.1016/j.vaccine.2008.03.041
Ooi M H, Solomon T, Podin Y, Mohan A, Akin W, Yusuf M A, del Sel S, Kontol K M, Lai B F, Clear D, Chieng C H, Blake E, Perera D, Wong S C, Cardosa J. Evaluation of different clinical sample types in diagnosis of human enterovirus71-associated hand-foot-and-mouth disease. J Clin Microbiol, 2007, 45(6): 1858–1866

doi: 10.1128/JCM.01394-06
Perez-Velez C M, Anderson M S, Robinson C C, McFarland E J, Nix W A, Pallansch M A, Oberste M S, Glode M P. Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Clin Infect Dis, 2007, 45(8): 950–957

doi: 10.1086/521895
Ooi M H, Wong S C, Mohan A, Podin Y, Perera D, Clear D, del Sel S, Chieng C H, Tio P H, Cardosa M J, Solomon T. Identification and validationof clinical predictors for the risk of neurological involvement inchildren with hand, foot, and mouth disease in Sarawak. BMC Infect Dis, 2009, 9: 3

doi: 10.1186/1471-2334-9-3
Chen K T, Chang H L, Wang S T, Cheng Y T, Yang J Y. Epidemiologic features ofhand-foot-mouth disease and herpangina caused by enterovirus 71 inTaiwan, 1998―2005. Pediatrics, 2007, 120(2): e244–252

doi: 10.1542/peds.2006-3331
Podin Y, Gias E L, Ong F, Leong Y W, Yee S F, Yusof M A, Perera D, Teo B, Wee T Y, Yao S C, Yao S K, Kiyu A, Arif M T, Cardosa M J. Sentinel surveillance for human enterovirus 71 in Sarawak,Malaysia: lessons from the first 7 years. BMC Public Health, 2006, 6: 180

doi: 10.1186/1471-2458-6-180
Chen S C, Chang H L, Yan T R, Cheng Y T, Chen K T. An eight-year study of epidemiologicfeatures of enterovirus 71 infection in Taiwan. Am J Trop Med Hyg, 2007, 77(1): 188–191
[1] Solmaz Ohadian Moghadam, Seyed Ali Momeni. Human microbiome and prostate cancer development: current insights into the prevention and treatment[J]. Front. Med., 2021, 15(1): 11-32.
[2] Guangbiao Zhou, Saijuan Chen, Zhu Chen. Advances in COVID-19: the virus, the pathogenesis, and evidence-based control and therapeutic strategies[J]. Front. Med., 2020, 14(2): 117-125.
[3] Min Zhou, Xinxin Zhang, Jieming Qu. Coronavirus disease 2019 (COVID-19): a clinical update[J]. Front. Med., 2020, 14(2): 126-135.
[4] Fanghua Gong, Yong Xiong, Jian Xiao, Li Lin, Xiaodong Liu, Dezhong Wang, Xiaokun Li. China’s local governments are combating COVID-19 with unprecedented responses ---- from a Wenzhou governance perspective[J]. Front. Med., 2020, 14(2): 220-224.
[5] Honglu Zhou, Songmei Wang, Lorenz von Seidlein, Xuanyi Wang. The epidemiology of norovirus gastroenteritis in China: disease burden and distribution of genotypes[J]. Front. Med., 2020, 14(1): 1-7.
[6] Xiaoxin Wu, Lanlan Xiao, Lanjuan Li. Research progress on human infection with avian influenza H7N9[J]. Front. Med., 2020, 14(1): 8-20.
[7] Eun Young Lee, Kun-Ho Yoon. Epidemic obesity in children and adolescents: risk factors and prevention[J]. Front. Med., 2018, 12(6): 658-666.
[8] Chongguang Yang, Qian Gao. Recent transmission of Mycobacterium tuberculosis in China: the implication of molecular epidemiology for tuberculosis control[J]. Front. Med., 2018, 12(1): 76-83.
[9] Min Chen, Yuan Xu, Nan Hong, Yali Yang, Wenzhi Lei, Lin Du, Jingjun Zhao, Xia Lei, Lin Xiong, Langqi Cai, Hui Xu, Weihua Pan, Wanqing Liao. Epidemiology of fungal infections in China[J]. Front. Med., 2018, 12(1): 58-75.
[10] Jikai Liu, Li Bai, Weiwei Li, Haihong Han, Ping Fu, Xiaochen Ma, Zhenwang Bi, Xiaorong Yang, Xiuli Zhang, Shiqi Zhen, Xiaoling Deng, Xiumei Liu, Yunchang Guo. Trends of foodborne diseases in China: lessons from laboratory-based surveillance since 2011[J]. Front. Med., 2018, 12(1): 48-57.
[11] Biao Kan, Haijian Zhou, Pengcheng Du, Wen Zhang, Xin Lu, Tian Qin, Jianguo Xu. Transforming bacterial disease surveillance and investigation using whole-genome sequence to probe the trace[J]. Front. Med., 2018, 12(1): 23-33.
[12] Tianhua Xu, Zitong Sheng, Li Yao. Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment[J]. Front. Med., 2017, 11(3): 340-348.
[13] Fatemeh Mehravar,Soheil Rafiee,Behnaz Bazrafshan,Mahmoud Khodadost. Prevalence of asthma symptoms in Golestan schoolchildren aged 6–7 and 13–14 years in Northeast Iran[J]. Front. Med., 2016, 10(3): 345-350.
[14] Jeffrey H. Mandel,Christine Wendt,Charles Lo,Guangbiao Zhou,Marshall Hertz,Gurumurthy Ramachandran. Ambient air pollution and lung disease in China: health effects, study design approaches and future research[J]. Front. Med., 2015, 9(3): 392-400.
[15] Rui Yu,Rong Fan,Jinlin Hou. Chronic hepatitis B virus infection: epidemiology, prevention, and treatment in China[J]. Front. Med., 2014, 8(2): 135-144.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed